| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $342.4M | -6.8% |
| Cost of Revenue | $71.1M | +41.8% |
| Gross Profit | $271.3M | -14.4% |
| R&D Expense | $61.1M | -3.5% |
| SG&A Expense | $88.2M | +6.7% |
| Operating Income | -$841K | -103.0% |
| Interest Expense | $500K | -86.1% |
| Pre-tax Income | $9.8M | -59.8% |
| Income Tax | $6.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $186.6M | -46.6% |
| Accounts Receivable | $208.7M | -5.5% |
| Current Assets | $407.9M | -29.9% |
| Total Assets | $525.9M | -22.5% |
| Current Liabilities | $207.8M | +1.8% |
| Long-term Debt | $0 | — |
| Total Liabilities | $238.3M | +7.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $95.3M | -17.8% |
| Capital Expenditures | $20.3M | +2229.9% |
| Investing Cash Flow | -$34.3M | -236.3% |
| Financing Cash Flow | -$224.0M | -223.5% |
| Free Cash Flow | $75.0M | -34.8% |
| +114.2% |
| Net Income | $3.6M | -94.8% |
| EPS (Basic) | $0.13 | -95.4% |
| EPS (Diluted) | $0.12 | -95.3% |
| Stockholders' Equity |
| $287.7M |
| -37.1% |